Dapagliflozin in heart failure

19th April 2021 by Dr Louise Hudman

Dapagliflozin in heart failure

This is a new guideline from NICE, published in February, advising that dapagliflozin can now be used in heart failure.

Isn’t dapagliflozin for diabetes?

Yes it is. It is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It reduces glucose reabsorption in the kidneys.

As it does this, it also reduces sodium reabsorption. This increased excretion leads to an osmotic diuresis.

Read for free

Sign up to access everything.

Three-month free trial

Login

Already a member? Login to view this content.

Login

Related content

"My accountant husband said that invoicing on LocumDeck was very impressive. Incredibly easy to use and intuitive – excellent piece of work."

Dr Daphne Hazel

Dr Daphne Hazel

See the full list of features within our NASGP membership plans

Membership